Investors Have Chance to Lead Securities Fraud Lawsuit Against Hims & Hers Health
News provided byHims & Hers Health, Inc · 1 min read
LOS ANGELES, Sept. 4, 2026 /CourierPR/ -- Investors in Hims & Hers Health, Inc. (HIMS) who have suffered financial losses due to alleged securities fraud now have an opportunity to lead a class action lawsuit, according to a recent announcement from The Law Offices of Frank R. Cruz.
The law firm has informed investors that they have the chance to take a leading role in the ongoing securities fraud lawsuit. Investors who believe they have been affected are urged to act quickly by clicking on a provided link or contacting the law firm before November 2, 2026, which is the deadline for selecting a lead plaintiff.
According to the complaint, the lawsuit alleges that between August 4, 2025, and July 29, 2026, the company and its management made misleading statements and failed to disclose important information about their business practices and prospects. Specifically, the complaint states that HIMS:
1. Shared consumers' health information with third-party advertising platforms. 2. Charged consumers for prescriptions almost immediately after they submitted an intake form, despite claiming to provide consultations. 3. Subjected the company to regulatory scrutiny due to the aforementioned practices. 4. Incurred fees and penalties as a result of these practices. 5. Misled investors with their positive statements about the company's financial health.
"These allegations, if proven, suggest a significant misrepresentation of HIMS's operations and financial condition," said Frank R. Cruz, managing partner of The Law Offices of Frank R. Cruz. "Investors who suffered losses as a result of these practices should not delay in participating in the lawsuit."
Investors are advised to provide their mailing address, telephone number, and the number of shares purchased if they wish to inquire by email. Participation in the class action is not mandatory at this time, and investors can choose to retain their own legal counsel or remain as part of the class action without taking any immediate action.